Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
STARD3NL-MET fusion
i
Other names:
DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase, STARD3NL, STARD3 N-Terminal Like, MENTHO, MLN64 N-Terminal Domain Homolog, STARD3 N-Terminal-Like Protein, STARD3NL, MGC3251
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4233
;
83930
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
HLA-DRB1-MET fusion (3)
KIF5B-MET fusion (2)
MET fusion (2)
MET-ATXN7L1 fusion (2)
CD47-MET fusion (1)
EHBP1‐MET fusion (1)
KIF5B-MET fusion + MET-CDR2 fusion (1)
MET-TNS3 fusion (1)
MET-TRIM4 fusion (1)
MET-UBE2H fusion (1)
PRKAR1A-MET fusion (1)
RBPMS-MET fusion (1)
HLA-DRB1-MET fusion (3)
KIF5B-MET fusion (2)
MET fusion (2)
MET-ATXN7L1 fusion (2)
CD47-MET fusion (1)
EHBP1‐MET fusion (1)
KIF5B-MET fusion + MET-CDR2 fusion (1)
MET-TNS3 fusion (1)
MET-TRIM4 fusion (1)
MET-UBE2H fusion (1)
PRKAR1A-MET fusion (1)
RBPMS-MET fusion (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
STARD3NL-MET fusion
Lung Adenocarcinoma
STARD3NL-MET fusion
Lung Adenocarcinoma
crizotinib
Sensitive: C4 – Case Studies
crizotinib
Sensitive
:
C4
crizotinib
Sensitive: C4 – Case Studies
crizotinib
Sensitive
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.